HY-108573-10mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108573-100mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108573-2mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108573-5mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108573-50mg
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0]
|
|
COVID-19-immunoregulation
|
|
HY-108573-1mL
|
MedChemexpress LLC
|
P-1075 [CAS 60559-98-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-111278-10mg
|
MedChemexpress LLC
|
Pyocyanin [CAS 85-66-5]
|
|
COVID-19-immunoregulation
|
|
HY-111278-100mg
|
MedChemexpress LLC
|
Pyocyanin [CAS 85-66-5]
|
|
COVID-19-immunoregulation
|
|
HY-111278-25mg
|
MedChemexpress LLC
|
Pyocyanin [CAS 85-66-5]
|
|
COVID-19-immunoregulation
|
|
HY-111278-5mg
|
MedChemexpress LLC
|
Pyocyanin [CAS 85-66-5]
|
|
COVID-19-immunoregulation
|
|
HY-111278-50mg
|
MedChemexpress LLC
|
Pyocyanin [CAS 85-66-5]
|
|
COVID-19-immunoregulation
|
|
HY-N0692-10mg
|
MedChemexpress LLC
|
Schisandrol B [CAS 58546-54-6]
|
|
Cancer-programmed cell death
|
|
HY-N0692-100mg
|
MedChemexpress LLC
|
Schisandrol B [CAS 58546-54-6]
|
|
Cancer-programmed cell death
|
|
HY-N0692-25mg
|
MedChemexpress LLC
|
Schisandrol B [CAS 58546-54-6]
|
|
Cancer-programmed cell death
|
|
HY-N0692-5mg
|
MedChemexpress LLC
|
Schisandrol B [CAS 58546-54-6]
|
|
Cancer-programmed cell death
|
|
HY-N0692-50mg
|
MedChemexpress LLC
|
Schisandrol B [CAS 58546-54-6]
|
|
Cancer-programmed cell death
|
|
HY-N0692-1mL
|
MedChemexpress LLC
|
Schisandrol B [CAS 58546-54-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-N0069-1mg
|
MedChemexpress LLC
|
Solamargine [CAS 20311-51-7]
|
|
Cancer-programmed cell death
|
|
HY-N0069-10mg
|
MedChemexpress LLC
|
Solamargine [CAS 20311-51-7]
|
|
Cancer-programmed cell death
|
|
HY-N0069-5mg
|
MedChemexpress LLC
|
Solamargine [CAS 20311-51-7]
|
|
Cancer-programmed cell death
|
|
HY-N0069-50mg
|
MedChemexpress LLC
|
Solamargine [CAS 20311-51-7]
|
|
Cancer-programmed cell death
|
|
HY-N0069-1mL
|
MedChemexpress LLC
|
Solamargine [CAS 20311-51-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-163002-10mg
|
MedChemexpress LLC
|
viFSP1 [CAS 951945-67-8]
|
|
Cancer-programmed cell death
|
|
HY-163002-5mg
|
MedChemexpress LLC
|
viFSP1 [CAS 951945-67-8]
|
|
Cancer-programmed cell death
|
|
HY-W015273-1g
|
MedChemexpress LLC
|
3-Indoleacrylic acid [CAS 1204-06-4]
|
|
|
|